Curious to hear more from Dr. Majed Alghamdi? Read his full interview in Issue 11 of the Rad Onc Student Scan! zurl.co/BnJ3S

ARPA-H Launches Initiative to Revolutionize Cancer Treatment 🔗 Learn more: zurl.co/1aO03

The Use of Adaptive Radiation in a Retroperitoneal Seminoma Patient with Poor Candidacy for Chemotherapy: A Teaching Case Learn more 🔗 zurl.co/7MaUr

Adenosquamous carcinoma of the nasal cavity is an extremely rare, aggressive tumor with distinct features; this case report reviews its management and existing literature. Learn more 🔗 zurl.co/df0W1

Research Article: To assess and compare tolerability for standard-of-care treatments and evaluate outcomes in older and younger patients with oropharyngeal cancer (OPC). 🔗 zurl.co/gSme0

Expanding Lung Cancer Screening to Never-Smokers: Promising Developments 🔗 zurl.co/L1JhZ Recent findings suggest that lung cancer screening via LDCT could be beneficial for individuals who have never smoked, a group for which lung cancer incidence is increasing.

Patient education needs a rethink: Empowering the Cancer Patient Journey through AI-Driven Education with 5thPort 🔗 Learn more zurl.co/GNPCs

This study evaluated the effectiveness of a peer-review process to objectively assess the skills of radiation oncology (RO) resident physicians (RPs) in contour grading of head and neck (HN) malignancies. Learn more 🧠 zurl.co/yq78a

In our recent survey of graduating RO residents,1 over 90% of residents report high overall program satisfaction and ~80% felt they had appropriate autonomy; however, disparities exist in perceived confidence across specialized treatment modalities. Read more 🔗 zurl.co/cCCKs

Want to hear more from Samir H. Patel, MD, a distinguished radiation oncologist currently serving as professor and vice chair of the Department of Radiation Oncology at Mayo Clinic in Phoenix, Arizona? Check out our interview in the RadOnc Student Scan (Issue 7) zurl.co/jJAzE

This Head and Neck Cancer Awareness Month, we recognize the patients, providers, and progress driving better outcomes. Stay informed on the latest in radiation oncology and multidisciplinary care with us all month!

Theranostics is reshaping precision cancer care. On Dr. Saul Hertz World Theranostics Day, we recognize how targeted radiopharmaceutical therapy is expanding the radiation oncology toolkit. The future isn’t one modality—it’s a more connected approach.

Massive spinal ependymoma: An intriguing case and review of the literature Learn more 🔗 zurl.co/iEHki

FDA Approves New PYLARIFY TruVu Formulation for Enhanced Prostate Cancer Imaging Learn more 🔗 zurl.co/QfpAJ This innovation aims to address the increasing demand for precise imaging, ultimately enhancing diagnostic accuracy and patient outcomes.

WHM Spotlight: Janet Lane-Claypon, MD, a pioneer in epidemiology and cancer research. Her early studies helped identify breast cancer risk factors, advancing understanding of cancer patterns and informing research, prevention, and treatment.

Radiation oncologists combine clinical expertise with advanced technology to deliver targeted treatment while protecting healthy tissue. On National Doctors’ Day, we recognize the physicians behind every carefully planned dose and every patient-centered decision.

Research Article: Using an Auto-Planned VMAT-TBI Technique for Myeloablative Autologous Hematopoietic Stem Cell Transplantation for Scleroderma (The STAT-2 Trial) 🔗 Learn more: zurl.co/pZyZV

Which noninvasive screening test is more effective for colorectal cancer? A new study found CT colonography reduced cancer risk more than stool DNA testing (70–75% vs 59%) and was more cost-effective in screening models. 🔗 Read more: zurl.co/hc2az

WHM Spotlight: Irène Joliot-Curie, DSc, discovered artificial radioactivity, earning the 1935 Nobel Prize in Chemistry. Her breakthrough enabled the production of radioactive isotopes used in cancer diagnosis and treatment, helping lay the groundwork for modern radiation oncology.

Curious to hear more from Joseph Salama, MD, a professor of radiation oncology and the program director of Duke University’s radiation oncology program? 🎓🔗 Check out our interview in the RadOnc Student Scan zurl.co/PL3oJ

For radiation oncologists, every decision carries weight—balancing precision, innovation, and compassion to deliver the best possible outcomes for patients. As cancer care continues to evolve, your expertise remains at the center of it all. Thank you for the work you do.

AI is changing the way residents learn — automating tasks like segmentation and planning while challenging traditional training models. This article explores how to integrate AI tools without compromising clinical judgment and core skills. Read more 🔗 zurl.co/pgxUN

Can AI help detect metastatic disease earlier? A study found that AI-assisted CT interpretation increased sensitivity for lung metastases in colorectal cancer patients by 40%, while maintaining high specificity. 🔗 Read more: zurl.co/ZExzQ

WHM Spotlight: Jimmie C. Holland, MD, is widely recognized as the founder of psycho-oncology, the field focused on the psychological aspects of cancer care. Her work helped integrate mental health support into oncology care, improving quality of life for patients undergoing cancer treatment.

FDA Approves New PYLARIFY TruVu Formulation for Enhanced Prostate Cancer Imaging 🔗 zurl.co/22vPU This innovation aims to address the increasing demand for precise imaging, ultimately enhancing diagnostic accuracy and patient outcomes.

AI-Enhanced Mammography Improves Risk Prediction in Breast Cancer Screening 🔗 zurl.co/r5WuM The study emphasizes the potential role of AI in enhancing the precision of mammo screening programs by allowing clinicians to allocate resources more effectively based on individual risk assessments.

Two proteins—fibronectin and smooth muscle actin—may help explain why some metastatic colorectal cancers resist immunotherapy, according to new research. 🔗 Read more: zurl.co/8booz

The motivation for change was clear: ChristianaCare urgently needed a consistent, verifiable "teach-back" platform that could scale with their growing volume while combatting physician burnout. Their search led them to 5thPort, a startup based in Delaware. Learn more 🔗 zurl.co/eZZO8

Health outcomes shouldn’t depend on ZIP codes — yet disparities persist. This article connects the dots between public policy, socioeconomic conditions, and cancer care access, and calls on clinicians to advocate for systemic change. Read more💡📊 zurl.co/EkGwp

WHM Spotlight: Jane Cooke Wright, MD, helped establish modern chemotherapy as a major cancer treatment. Her work developing methods to test anticancer drugs and tailor treatment helped advance today’s multidisciplinary model of cancer care, combining chemotherapy, radiation therapy, and surgery.

Want to hear more from John Hillson, DNP, a radiation oncology nurse practitioner specializing in head and neck cancer at Atrium Health Wake Forest Baptist Medical Center? 🔗 zurl.co/E5oTO

Enhancing Patient Safety with Advanced Radiation Dosimetry 🔗 zurl.co/ZyVrB By spearheading international efforts in dosimetry enhancement, the IAEA continues to play a fundamental role in improving cancer treatment outcomes, ensuring both safety and efficacy for patients worldwide.

A dual-isotope radionuclide therapy approach combining alpha- and beta-emitters showed promising activity against colorectal cancer in preclinical research. 🔗 Read more: zurl.co/dELNO

WHM Spotlight: Mary Woodard Lasker was a powerful advocate for medical and cancer research funding. Her leadership and philanthropy helped expand support for biomedical research, accelerating progress in cancer science and the development of treatments—including advances in radiation oncology.

Colorectal cancer often metastasizes to the liver, but patients with limited disease may benefit from multimodality treatment—including surgery, systemic therapy, and radiation therapy. 🔗 Read more: zurl.co/XBKPX

Colorectal cancer outcomes are not equal across all populations. A new study explores disparities affecting young adults and African Americans in the United States, highlighting the need for more targeted research and improved access to care. 🔗 Read more: zurl.co/AFXAI

Key Milestones Achieved in ProstACT Global Phase 3 Study of TLX591-Tx 🔗 zurl.co/L78KG

Innovative Radiotheranostic Therapy Under Investigation for Aggressive Bone Cancer 🔗 zurl.co/a62tE

WHM Spotlight: Gerty Cori, MD, shared the 1947 Nobel Prize in Physiology or Medicine for discovering the Cori cycle. Her work on cellular metabolism helped advance the understanding of how cells generate and use energy—knowledge that continues to influence cancer biology and treatment research.

A new theranostics approach for colorectal cancer achieved 100% complete response and cured 40% of tumors in mice in a preclinical study. The targeted radioimmunotherapy strategy may allow higher radiation doses to tumors while protecting healthy tissue. 🔗 Read more: zurl.co/lHhBR

Want to hear more from Jillian R. Gunther, MD, PhD, associate professor of radiation oncology at MD Anderson Cancer Center? 🔗 Check out Issue 6 of the RadOnc Student Scan: zurl.co/zmZuH

Radiation oncology training can feel like being thrown into the deep end without a life jacket. 🏊‍♂️ 🔗zurl.co/nTnK8

WHM Spotlight: Tikvah Alper, PhD, was a pioneering radiobiologist who studied how radiation affects living systems. Her research advanced understanding of radiation’s effects on living systems—knowledge that underpins the field of radiobiology and its role in medicine.

Can AI help personalize colon cancer treatment? Researchers are using infrared imaging and deep learning to analyze tumor tissue and identify biomarkers that guide therapy decisions. 🔗 Learn more: zurl.co/FB6dJ

Patient education needs a rethink: Empowering the Cancer Patient Journey with AI-Driven Education 🔗 zurl.co/8aW6a

For Women's History Month, we celebrate Audrey E. Evans, MD on what would be her birthday (March 6, 1925)—a pioneer in pediatric oncology who developed the Evans Staging System for neuroblastoma and co-founded the first Ronald McDonald House. Her legacy continues to shape compassionate cancer care

Clinical trials are essential — but they’re not always environmentally sustainable. 🌍 This article lays out actionable strategies to reduce carbon footprints in oncology research (from telehealth to decentralized trials) while expanding patient access. 🔗 zurl.co/GERvE

"In a world where trimodality therapy has been the standard of care for so long, it’s remarkable to think that some of these cancers can be cured with a single systemic agent alone." 🔗 zurl.co/Sdb42

Curious to hear more from Deborah Bruner, RN, PhD, FAAN, senior vice president of research at Emory University? 🔗 Check out her full interview here: zurl.co/BlFs1

Before we understood HPV causes cancer, Dr. Yvonne Barr helped prove that viruses can drive malignancy. Today, for Women's History Month and HPV Awareness Day, we recognize the scientist whose work helped lay the foundation for today’s HPV research, prevention, and cancer treatment advances.